Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912647253> ?p ?o ?g. }
- W2912647253 endingPage "1295" @default.
- W2912647253 startingPage "1283" @default.
- W2912647253 abstract "Background: Heart failure (HF) and chronic kidney disease (CKD) are responsible for substantial morbidity and mortality in individuals with type 2 diabetes (T2D).Methods: This review discusses the significance of these comorbidities of T2D and current options for managing them, with a focus on sodium-glucose cotransporter-2 (SGLT-2) inhibitors. Based on a focused literature search of cardiovascular outcomes trials (CVOTs), this review assessed the effects of SGLT-2 inhibitors in individuals with T2D with or without established cardiovascular disease (CVD).Results: In addition to effective glycemic control and weight loss, SGLT-2 inhibitor treatment of T2D prevents adverse cardiovascular and renal outcomes in individuals with and without these comorbidities. Reduced rate of hospitalization due to HF (HHF) and improved renal outcomes appear to be class effects of SGLT-2 inhibitors. Reduction in CV events may be more significant in individuals with established cardiovascular disease.Conclusions: CVOTs and other studies confirm that the SGLT-2 inhibitors, mostly used in combination with other glucose-lowering drugs, offer several clinical benefits beyond improved glycemic control. These include reducing HHF risk and improving renal outcomes. HF and renal benefits are observed in individuals with and without established CVD, which may simplify therapeutic selection. Ongoing SGLT-2 inhibitor CVOTs will help clarify the potential of these drugs to treat T2D comorbid with different forms of HF (HF with preserved vs reduced ejection fraction) and different degrees of renal dysfunction, and in individuals with T2D vs pre-diabetes or normal glucose metabolism." @default.
- W2912647253 created "2019-02-21" @default.
- W2912647253 creator A5032297044 @default.
- W2912647253 creator A5038984550 @default.
- W2912647253 creator A5060475589 @default.
- W2912647253 creator A5064052704 @default.
- W2912647253 date "2019-02-15" @default.
- W2912647253 modified "2023-10-17" @default.
- W2912647253 title "The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes" @default.
- W2912647253 cites W1526122626 @default.
- W2912647253 cites W1664963969 @default.
- W2912647253 cites W1975966089 @default.
- W2912647253 cites W1997930168 @default.
- W2912647253 cites W2007374852 @default.
- W2912647253 cites W2015876671 @default.
- W2912647253 cites W2020353068 @default.
- W2912647253 cites W2023938374 @default.
- W2912647253 cites W2028533363 @default.
- W2912647253 cites W2033912474 @default.
- W2912647253 cites W2045432073 @default.
- W2912647253 cites W2049182490 @default.
- W2912647253 cites W2064130493 @default.
- W2912647253 cites W2067465076 @default.
- W2912647253 cites W2072535229 @default.
- W2912647253 cites W2093935755 @default.
- W2912647253 cites W2100778881 @default.
- W2912647253 cites W2101329765 @default.
- W2912647253 cites W2103701188 @default.
- W2912647253 cites W2107031719 @default.
- W2912647253 cites W2107195787 @default.
- W2912647253 cites W2109712401 @default.
- W2912647253 cites W2114250030 @default.
- W2912647253 cites W2114598208 @default.
- W2912647253 cites W2115360698 @default.
- W2912647253 cites W2135378280 @default.
- W2912647253 cites W2135729475 @default.
- W2912647253 cites W2139847317 @default.
- W2912647253 cites W2140802352 @default.
- W2912647253 cites W2142830692 @default.
- W2912647253 cites W2143239235 @default.
- W2912647253 cites W2144899887 @default.
- W2912647253 cites W2146264128 @default.
- W2912647253 cites W2147527649 @default.
- W2912647253 cites W2153454097 @default.
- W2912647253 cites W2164249826 @default.
- W2912647253 cites W2165832533 @default.
- W2912647253 cites W2166155176 @default.
- W2912647253 cites W2169630967 @default.
- W2912647253 cites W2171646682 @default.
- W2912647253 cites W2235343273 @default.
- W2912647253 cites W2273304042 @default.
- W2912647253 cites W2282578582 @default.
- W2912647253 cites W2282647732 @default.
- W2912647253 cites W2301210108 @default.
- W2912647253 cites W2335083084 @default.
- W2912647253 cites W2337454357 @default.
- W2912647253 cites W2424539745 @default.
- W2912647253 cites W2425644022 @default.
- W2912647253 cites W2444268874 @default.
- W2912647253 cites W2464585615 @default.
- W2912647253 cites W2488337536 @default.
- W2912647253 cites W2492672367 @default.
- W2912647253 cites W2498004564 @default.
- W2912647253 cites W2534221266 @default.
- W2912647253 cites W2553261268 @default.
- W2912647253 cites W2556842465 @default.
- W2912647253 cites W2567447584 @default.
- W2912647253 cites W2587062523 @default.
- W2912647253 cites W2596803679 @default.
- W2912647253 cites W2597545061 @default.
- W2912647253 cites W2604277961 @default.
- W2912647253 cites W2614137535 @default.
- W2912647253 cites W2626446274 @default.
- W2912647253 cites W2752707491 @default.
- W2912647253 cites W2760952310 @default.
- W2912647253 cites W2766617433 @default.
- W2912647253 cites W2768451744 @default.
- W2912647253 cites W2768576350 @default.
- W2912647253 cites W2770821084 @default.
- W2912647253 cites W2772844083 @default.
- W2912647253 cites W2790193266 @default.
- W2912647253 cites W2791264041 @default.
- W2912647253 cites W2793012836 @default.
- W2912647253 cites W2793355388 @default.
- W2912647253 cites W2795697937 @default.
- W2912647253 cites W2797054241 @default.
- W2912647253 cites W2797859454 @default.
- W2912647253 cites W2802967288 @default.
- W2912647253 cites W2806521060 @default.
- W2912647253 cites W2808467887 @default.
- W2912647253 cites W2808725516 @default.
- W2912647253 cites W2808915250 @default.
- W2912647253 cites W2808939545 @default.
- W2912647253 cites W2810458929 @default.
- W2912647253 cites W2810892857 @default.
- W2912647253 cites W2874659411 @default.
- W2912647253 cites W2890465901 @default.
- W2912647253 cites W2899764361 @default.